Annat Raiter
Petah Tiqwa, M, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Galectin-3 secreted by triple-negative breast cancer cells regulates T cell function.
Journal: Neoplasia (New York, N.Y.)
Published: September 02, 2024
Chemotherapy-Induced Cell-Surface GRP78 Expression as a Prognostic Marker for Invasiveness of Metastatic Triple-Negative Breast Cancer.
Journal: Annals of biomedical engineering
Published: January 30, 2024
TNBC-derived Gal3BP/Gal3 complex induces immunosuppression through CD45 receptor.
Journal: Oncoimmunology
Published: August 18, 2023
A novel role for an old target: CD45 for breast cancer immunotherapy.
Journal: Oncoimmunology
Published: June 09, 2021
Downregulation of CD45 Signaling in COVID-19 Patients Is Reversed by C24D, a Novel CD45 Targeting Peptide.
Journal: Frontiers in medicine
Published: March 04, 2021
Chemotherapy Controls Metastasis Through Stimulatory Effects on GRP78 and Its Transcription Factor CREB3L1.
Journal: Frontiers in oncology
Published: February 02, 2020
GRP78 expression in peripheral blood mononuclear cells is a new predictive marker for the benefit of taxanes in breast cancer neoadjuvant treatment.
Journal: BMC cancer
Published: May 12, 2019
Peptide Binding Glucose Regulated Protein 78 Improves Type 1 Diabetes by Preventing Pancreatic β Cell Apoptosis.
Journal: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
Published: April 29, 2016
Cell surface GRP78: A potential marker of good prognosis and response to chemotherapy in breast cancer.
Journal: Oncology letters
Published: November 05, 2014
The presence of anti-GRP78 antibodies in the serum of patients with colorectal carcinoma: a potential biomarker for early cancer detection.
Journal: The International journal of biological markers
Published: April 09, 2014
Last Updated: 09/26/2026